+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years - 90Years
All Genders
ID05263206

Evaluation of Dupilumab Compared to Placebo for Adults With Chronic Pruritus of Unknown Origin in Two Parallel Randomized Controlled Studies

Led by Sanofi · Updated on 2026-10-15

284

Participants Needed

94

Research Sites

12 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of dupilumab in adults with chronic pruritus of unknown origin CPUO, a condition causing severe itching without a clear cause. This Phase 3 study includes two parallel, double-blind clinical trials involving men and women aged 18 to 90 years who have experienced severe itching for at least six months. The trials aim to compare dupilumab with a placebo while both groups also use a non-sedative antihistamine and moisturizer. After up to a 4-week screening, participants with severe itch enter a 4-week run-in period receiving antihistamines and moisturizers. Those still experiencing severe itching are randomly assigned to receive either dupilumab or placebo injections subcutaneously every two weeks for 24 weeks, alongside their existing treatments. Following this, all participants enter a 12-week follow-up period to monitor outcomes. Participants attend regular visits for assessments including itch severity ratings, quality of life questionnaires, and anxiety and depression scales. Researchers will measure changes in itch intensity, sleep disturbance, and life quality over time. Safety is closely monitored throughout the treatment and follow-up periods, with the total participation lasting up to 44 weeks.

CONDITIONS

Brief Title

Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)

Research Team

T

Trial Transparency email recommended (Toll free number for US & Canada)

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here